311 related articles for article (PubMed ID: 17629751)
41. Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
Choi YW; Ahn MS; Jeong GS; Lee HW; Jeong SH; Kang SY; Park JS; Choi JH; Lee SY
Lung Cancer; 2015 Feb; 87(2):155-61. PubMed ID: 25488862
[TBL] [Abstract][Full Text] [Related]
42. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.
Andre F; Grunenwald D; Pignon JP; Dujon A; Pujol JL; Brichon PY; Brouchet L; Quoix E; Westeel V; Le Chevalier T
J Clin Oncol; 2000 Aug; 18(16):2981-9. PubMed ID: 10944131
[TBL] [Abstract][Full Text] [Related]
43. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
[TBL] [Abstract][Full Text] [Related]
44. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
Aggarwal C; Langer CJ
Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
[TBL] [Abstract][Full Text] [Related]
45. Preoperative palsy score has no significant association with survival in non-small-cell lung cancer patients with spinal metastases who undergo spinal surgery.
Chen YJ; Chen HT; Hsu HC
J Orthop Surg Res; 2015 Sep; 10():149. PubMed ID: 26381378
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
Read JA; Choy ST; Beale PJ; Clarke SJ
Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
[TBL] [Abstract][Full Text] [Related]
47. Early palliative intervention for patients with advanced cancer.
Otsuka M; Koyama A; Matsuoka H; Niki M; Makimura C; Sakamoto R; Sakai K; Fukuoka M
Jpn J Clin Oncol; 2013 Aug; 43(8):788-94. PubMed ID: 23737605
[TBL] [Abstract][Full Text] [Related]
48. Significant progress in palliative treatment of non-small cell lung cancer in the past decade.
Waechter F; Passweg J; Tamm M; Brutsche M; Herrmann R; Pless M
Chest; 2005 Mar; 127(3):738-47. PubMed ID: 15764752
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with first-line cisplatin-based chemotherapy: a retrospective analysis of single institution.
Inal A; Kaplan MA; Kucukoner M; Karakus A; Isikdogan A
J BUON; 2012; 17(3):533-6. PubMed ID: 23033295
[TBL] [Abstract][Full Text] [Related]
50. The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy.
Vincent M; Dranitsaris G; Verma S; Lau C; Gascon P; Van Belle S; Ludwig H
Support Care Cancer; 2007 Mar; 15(3):265-72. PubMed ID: 17120069
[TBL] [Abstract][Full Text] [Related]
51. The Glasgow prognostic score as a prognostic factor in patients with advanced non-small cell lung cancer treated with cisplatin-based first-line chemotherapy.
Jiang AG; Lu HY
J Chemother; 2015 Feb; 27(1):35-9. PubMed ID: 24716851
[TBL] [Abstract][Full Text] [Related]
52. Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.
Di Maio M; Lama N; Morabito A; Smit EF; Georgoulias V; Takeda K; Quoix E; Hatzidaki D; Wachters FM; Gebbia V; Tsai CM; Camps C; Schuette W; Chiodini P; Piccirillo MC; Perrone F; Gallo C; Gridelli C
Eur J Cancer; 2010 Mar; 46(4):735-43. PubMed ID: 20045311
[TBL] [Abstract][Full Text] [Related]
53. Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors.
Hickish TF; Smith IE; O'Brien ME; Ashley S; Middleton G
Br J Cancer; 1998 Jul; 78(1):28-33. PubMed ID: 9662246
[TBL] [Abstract][Full Text] [Related]
54. Patient-reported symptoms before palliative radiotherapy predict survival differences.
Nieder C; Kämpe TA; Pawinski A; Dalhaug A
Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness of structured nursing assessment of symptom distress in advanced lung cancer.
Sarna L
Oncol Nurs Forum; 1998 Jul; 25(6):1041-8. PubMed ID: 9679262
[TBL] [Abstract][Full Text] [Related]
56. Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer.
Müller H
Eur J Surg Oncol; 2002 Mar; 28(2):165-71. PubMed ID: 11884052
[TBL] [Abstract][Full Text] [Related]
57. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery.
Chiou SM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1156-62. PubMed ID: 20970031
[TBL] [Abstract][Full Text] [Related]
58. Predicting the need for palliative thoracic radiation after first-line chemotherapy for advanced nonsmall cell lung carcinoma.
Higginson DS; Chen RC; Morris DE; Halle J; Rosenman JG; Socinski MA; Marks LB
Cancer; 2012 May; 118(10):2744-51. PubMed ID: 21935913
[TBL] [Abstract][Full Text] [Related]
59. Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
Gwak HS; Joo J; Kim S; Yoo H; Shin SH; Han JY; Kim HT; Lee JS; Lee SH
J Thorac Oncol; 2013 May; 8(5):599-605. PubMed ID: 23422833
[TBL] [Abstract][Full Text] [Related]
60. The role of palliative radiotherapy in locally advanced non-small cell lung cancer.
Cetingoz R; Kentli S; Uruk O; Demirtas E; Sen M; Kinay M
Neoplasma; 2001; 48(6):506-10. PubMed ID: 11949846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]